QR-Code

Dose-dependent antiviral effects of glycyrrhizin, curcumin, and harmaline against clinical SARS-CoV-2 isolates, including D614G, Omicron BA.5, and Omicron XBB.1

Abstract Background SARS-CoV-2 remains a major global health challenge, as infection can lead to potential life-threatening conditions such as COVID-19. Emerging variants of the virus are characterized by higher transmission rates and immune escape mutations, enabling them to evade vaccine-induced i...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Rabea Grüneberg, Isabel Zydek, Carina Elsner, Evelyn Scheiermann, Ulf Dittmer, Folker Meyer, Ivana Kraiselburd, Hana Rohn, Oliver Witzke, Laura Thümmler, Adalbert Krawczyk
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMC 2026-01-01
Schriftenreihe:BMC Complementary Medicine and Therapies
Schlagworte:
Glycyrrhizin
Curcumin
Harmaline
SARS-CoV-2
COVID-19
Online-Zugang:https://doi.org/10.1186/s12906-026-05253-1
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge